Search Results - "Gettings, Kelly F."

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
  2. 2
  3. 3

    An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions by Blumberg, Neil, Gettings, Kelly F., Turner, Chantal, Heal, Joanna M., Phipps, Richard P.

    Published in Transfusion (Philadelphia, Pa.) (01-10-2006)
    “…BACKGROUND: Removal of stored supernatant abrogates most transfusion reactions to leukoreduced platelets (PLTs), suggesting that PLT‐derived soluble mediators…”
    Get full text
    Journal Article
  4. 4

    Human bone marrow megakaryocytes and platelets express PPARγ, and PPARγ agonists blunt platelet release of CD40 ligand and thromboxanes by Akbiyik, Filiz, Ray, Denise M., Gettings, Kelly F., Blumberg, Neil, Francis, Charles W., Phipps, Richard P.

    Published in Blood (01-09-2004)
    “…Peroxisome proliferator-activated receptor γ (PPARγ) is a ligand-activated transcription factor important in lipid metabolism, diabetes, and inflammation. We…”
    Get full text
    Journal Article
  5. 5

    WBC reduction of RBC transfusions is associated with a decreased incidence of RBC alloimmunization by Blumberg, Neil, Heal, Joanna M., Gettings, Kelly F.

    Published in Transfusion (Philadelphia, Pa.) (01-07-2003)
    “…BACKGROUND: Allogeneic transfusion stimulates Th2 (humoral) immunity. A hypothesis was developed that WBC reduction, by reducing the Th2 stimulus associated…”
    Get full text
    Journal Article
  6. 6

    Decreased sepsis related to indwelling venous access devices coincident with implementation of universal leukoreduction of blood transfusions by Blumberg, Neil, Fine, Lynn, Gettings, Kelly F., Heal, Joanna M.

    Published in Transfusion (Philadelphia, Pa.) (01-10-2005)
    “…BACKGROUND: Randomized trials and animal models demonstrate that leukoreduction of transfusions can reduce the risk of post‐operative infections. We performed…”
    Get full text
    Journal Article
  7. 7

    Developmental Changes in Soluble CD40 Ligand by Cholette, Jill M., MD, Blumberg, Neil, MD, Phipps, Richard P., PhD, McDermott, Michael P., PhD, Gettings, Kelly F, Lerner, Norma B., MD, MPH

    Published in The Journal of pediatrics (2008)
    “…Objectives To determine if soluble CD40 ligand (sCD40L; formally CD154) levels vary with age and to identify age-dependent ranges in healthy pediatric and…”
    Get full text
    Journal Article
  8. 8

    ABO Mismatched Platelet, Plasma and Cryoprecipitate Transfusions and Bleeding in Transfused Surgical Patients by Blumberg, Neil, Gettings, Kelly F., Heal, Joanna M.

    Published in Blood (16-11-2005)
    “…Three observations led us to investigate whether infusion of ABO non-identical platelets might impair, rather than improve hemostasis. (1) Exposure of…”
    Get full text
    Journal Article
  9. 9
  10. 10

    TRANSFUSION PRACTICES: Decreased sepsis related to indwelling venous access devices coincident with implementation of universal leukoreduction of blood transfusions by Blumberg, Neil, Fine, Lynn, Gettings, Kelly F, Heal, Joanna M

    Published in Transfusion (Philadelphia, Pa.) (01-10-2005)
    “…BACKGROUND:Randomized trials and animal models demonstrate that leukoreduction of transfusions can reduce the risk of post-operative infections. We performed a…”
    Get full text
    Journal Article
  11. 11

    TRANSFUSION COMPLICATIONS: An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions by Blumberg, Neil, Gettings, Kelly F, Turner, Chantal, Heal, Joanna M, Phipps, Richard P

    Published in Transfusion (Philadelphia, Pa.) (01-10-2006)
    “…BACKGROUND:Removal of stored supernatant abrogates most transfusion reactions to leukoreduced platelets (PLTs), suggesting that PLT-derived soluble mediators…”
    Get full text
    Journal Article
  12. 12

    Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes by Akbiyik, Filiz, Ray, Denise M, Gettings, Kelly F, Blumberg, Neil, Francis, Charles W, Phipps, Richard P

    Published in Blood (01-09-2004)
    “…Peroxisome proliferator-activated receptor gamma (PPARgamma) is a ligand-activated transcription factor important in lipid metabolism, diabetes, and…”
    Get full text
    Journal Article
  13. 13

    CD40 Ligand (CD154) as a Cofactor in the Development of Transfusion Related Acute Lung Injury (TRALI) by Blumberg, Neil, Boshkov, Lynn K., Silliman, Christopher C., Kelher, Marguerite, Gettings, Kelly F., Heal, Joanna M., Phipps, Richard P.

    Published in Blood (16-11-2004)
    “…TRALI is post-transfusion acute pulmonary dysfunction with non-cardiogenic pulmonary edema and profound hypoxia. A number of biologic response mediators(BRMs)…”
    Get full text
    Journal Article